Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Jun;93(6):2324–2331. doi: 10.1172/JCI117237

Enzyme replacement therapy for murine mucopolysaccharidosis type VII.

M S Sands 1, C Vogler 1, J W Kyle 1, J H Grubb 1, B Levy 1, N Galvin 1, W S Sly 1, E H Birkenmeier 1
PMCID: PMC294437  PMID: 8200966

Abstract

Recombinant mouse beta-glucuronidase administered intravenously to newborn mice with mucopolysaccharidosis type VII (MPS VII) is rapidly cleared from the circulation and localized in many tissues. Here we determine the tissue distribution of injected enzyme and describe its effects on the histopathology in 6-wk-old MPS VII mice that received either one injection of 28,000 U recombinant beta-glucuronidase at 5 wk of age or received six injections of 28,000 U given at weekly intervals beginning at birth. These mice were compared with untreated 6-wk-old MPS VII mice. The single injection decreased lysosomal distention in the fixed tissue macrophage system. MPS VII mice that received multiple injections had 27.8, 3.5, and 3.3% of normal levels of beta-glucuronidase in liver, spleen, and kidney, respectively. Brain had detectable beta-glucuronidase, ranging from 2.0-12.1% of normal. Secondary elevations of alpha-galactosidase and beta-hexosaminidase in brain, spleen, liver, and kidney were decreased compared with untreated MPS VII mice. Although no improvement was observed in chondrocytes, glia, and some neurons, the skeleton had less clinical and pathological evidence of disease and the brain had reduced lysosomal storage in meninges and selected neuronal groups. These data show that recombinant beta-glucuronidase treatment begun in newborn MPS VII mice provides enzyme to most tissues and significantly reduces or prevents the accumulation of lysosomal storage during the first 6 wk of life. Whether therapy begun later in life can achieve this level of correction remains to be established.

Full text

PDF
2324

Images in this article

2326Image
on p.2326
2326Image
on p.2326
2326Image
on p.2326
2326Image
on p.2326
2326Image
on p.2326
2326Image
on p.2326
2327Image
on p.2327
2327Image
on p.2327
2327Image
on p.2327
2327Image
on p.2327
2328Image
on p.2328
2329Image
on p.2329
2329Image
on p.2329
2329Image
on p.2329
2329Image
on p.2329
2329Image
on p.2329
2329Image
on p.2329
2329Image
on p.2329
2329Image
on p.2329

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Achord D. T., Brot F. E., Bell C. E., Sly W. S. Human beta-glucuronidase: in vivo clearance and in vitro uptake by a glycoprotein recognition system on reticuloendothelial cells. Cell. 1978 Sep;15(1):269–278. doi: 10.1016/0092-8674(78)90102-2. [DOI] [PubMed] [Google Scholar]
  2. Achord D., Brot F., Gonzalez-Noriega A., Sly W., Stahl P. Human beta-glucuronidase. II. Fate of infused human placental beta-glucuronidase in the rat. Pediatr Res. 1977 Jul;11(7):816–822. doi: 10.1203/00006450-197707000-00008. [DOI] [PubMed] [Google Scholar]
  3. Barker J. E., McFarland E. The hematopoietic stem cells of alpha-thalassemic mice. Blood. 1985 Sep;66(3):595–601. [PubMed] [Google Scholar]
  4. Barton N. W., Brady R. O., Dambrosia J. M., Di Bisceglie A. M., Doppelt S. H., Hill S. C., Mankin H. J., Murray G. J., Parker R. I., Argoff C. E. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med. 1991 May 23;324(21):1464–1470. doi: 10.1056/NEJM199105233242104. [DOI] [PubMed] [Google Scholar]
  5. Barton N. W., Brady R. O., Dambrosia J. M., Doppelt S. H., Hill S. C., Holder C. A., Mankin H. J., Murray G. J., Zirzow G. C., Parker R. I. Dose-dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher disease. J Pediatr. 1992 Feb;120(2 Pt 1):277–280. doi: 10.1016/s0022-3476(05)80444-5. [DOI] [PubMed] [Google Scholar]
  6. Beutler E., Kay A., Saven A., Garver P., Thurston D., Dawson A., Rosenbloom B. Enzyme replacement therapy for Gaucher disease. Blood. 1991 Sep 1;78(5):1183–1189. [PubMed] [Google Scholar]
  7. Birkenmeier E. H., Barker J. E., Vogler C. A., Kyle J. W., Sly W. S., Gwynn B., Levy B., Pegors C. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood. 1991 Dec 1;78(11):3081–3092. [PubMed] [Google Scholar]
  8. Birkenmeier E. H., Davisson M. T., Beamer W. G., Ganschow R. E., Vogler C. A., Gwynn B., Lyford K. A., Maltais L. M., Wawrzyniak C. J. Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency. J Clin Invest. 1989 Apr;83(4):1258–1266. doi: 10.1172/JCI114010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  10. Doebber T. W., Wu M. S., Bugianesi R. L., Ponpipom M. M., Furbish F. S., Barranger J. A., Brady R. O., Shen T. Y. Enhanced macrophage uptake of synthetically glycosylated human placental beta-glucocerebrosidase. J Biol Chem. 1982 Mar 10;257(5):2193–2199. [PubMed] [Google Scholar]
  11. Fischer H. D., Gonzalez-Noriega A., Sly W. S. Beta-glucuronidase binding to human fibroblast membrane receptors. J Biol Chem. 1980 Jun 10;255(11):5069–5074. [PubMed] [Google Scholar]
  12. Gabel C. A., Goldberg D. E., Kornfeld S. Identification and characterization of cells deficient in the mannose 6-phosphate receptor: evidence for an alternate pathway for lysosomal enzyme targeting. Proc Natl Acad Sci U S A. 1983 Feb;80(3):775–779. doi: 10.1073/pnas.80.3.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Haskins M. E., Desnick R. J., DiFerrante N., Jezyk P. F., Patterson D. F. Beta-glucuronidase deficiency in a dog: a model of human mucopolysaccharidosis VII. Pediatr Res. 1984 Oct;18(10):980–984. doi: 10.1203/00006450-198410000-00014. [DOI] [PubMed] [Google Scholar]
  14. Hoogerbrugge P. M., Poorthuis B. J., Romme A. E., van de Kamp J. J., Wagemaker G., van Bekkum D. W. Effect of bone marrow transplantation on enzyme levels and clinical course in the neurologically affected twitcher mouse. J Clin Invest. 1988 Jun;81(6):1790–1794. doi: 10.1172/JCI113521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kaplan A., Achord D. T., Sly W. S. Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts. Proc Natl Acad Sci U S A. 1977 May;74(5):2026–2030. doi: 10.1073/pnas.74.5.2026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kornfeld S. Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem. 1992;61:307–330. doi: 10.1146/annurev.bi.61.070192.001515. [DOI] [PubMed] [Google Scholar]
  17. Maréchal V., Naffakh N., Danos O., Heard J. M. Disappearance of lysosomal storage in spleen and liver of mucopolysaccharidosis VII mice after transplantation of genetically modified bone marrow cells. Blood. 1993 Aug 15;82(4):1358–1365. [PubMed] [Google Scholar]
  18. Matzner U., von Figura K., Pohlmann R. Expression of the two mannose 6-phosphate receptors is spatially and temporally different during mouse embryogenesis. Development. 1992 Apr;114(4):965–972. doi: 10.1242/dev.114.4.965. [DOI] [PubMed] [Google Scholar]
  19. Moullier P., Bohl D., Heard J. M., Danos O. Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts. Nat Genet. 1993 Jun;4(2):154–159. doi: 10.1038/ng0693-154. [DOI] [PubMed] [Google Scholar]
  20. Sands M. S., Barker J. E., Vogler C., Levy B., Gwynn B., Galvin N., Sly W. S., Birkenmeier E. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab Invest. 1993 Jun;68(6):676–686. [PubMed] [Google Scholar]
  21. Sands M. S., Birkenmeier E. H. A single-base-pair deletion in the beta-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VII. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6567–6571. doi: 10.1073/pnas.90.14.6567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sato Y., Beutler E. Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages. J Clin Invest. 1993 May;91(5):1909–1917. doi: 10.1172/JCI116409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Senior P. V., Byrne S., Brammar W. J., Beck F. Expression of the IGF-II/mannose-6-phosphate receptor mRNA and protein in the developing rat. Development. 1990 May;109(1):67–73. doi: 10.1242/dev.109.1.67. [DOI] [PubMed] [Google Scholar]
  24. Shull R. M., Hastings N. E., Selcer R. R., Jones J. B., Smith J. R., Cullen W. C., Constantopoulos G. Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system. J Clin Invest. 1987 Feb;79(2):435–443. doi: 10.1172/JCI112830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sklar M. M., Kiess W., Thomas C. L., Nissley S. P. Developmental expression of the tissue insulin-like growth factor II/mannose 6-phosphate receptor in the rat. Measurement by quantitative immunoblotting. J Biol Chem. 1989 Oct 5;264(28):16733–16738. [PubMed] [Google Scholar]
  26. Sly W. S., Quinton B. A., McAlister W. H., Rimoin D. L. Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. J Pediatr. 1973 Feb;82(2):249–257. doi: 10.1016/s0022-3476(73)80162-3. [DOI] [PubMed] [Google Scholar]
  27. Vogler C., Birkenmeier E. H., Sly W. S., Levy B., Pegors C., Kyle J. W., Beamer W. G. A murine model of mucopolysaccharidosis VII. Gross and microscopic findings in beta-glucuronidase-deficient mice. Am J Pathol. 1990 Jan;136(1):207–217. [PMC free article] [PubMed] [Google Scholar]
  28. Vogler C., Sands M., Higgins A., Levy B., Grubb J., Birkenmeier E. H., Sly W. S. Enzyme replacement with recombinant beta-glucuronidase in the newborn mucopolysaccharidosis type VII mouse. Pediatr Res. 1993 Dec;34(6):837–840. doi: 10.1203/00006450-199312000-00028. [DOI] [PubMed] [Google Scholar]
  29. Wall D. A., Wilson G., Hubbard A. L. The galactose-specific recognition system of mammalian liver: the route of ligand internalization in rat hepatocytes. Cell. 1980 Aug;21(1):79–93. doi: 10.1016/0092-8674(80)90116-6. [DOI] [PubMed] [Google Scholar]
  30. Watson G., Felder M., Rabinow L., Moore K., Labarca C., Tietze C., Vander Molen G., Bracey L., Brabant M., Cai J. D. Properties of rat and mouse beta-glucuronidase mRNA and cDNA, including evidence for sequence polymorphism and genetic regulation of mRNA levels. Gene. 1985;36(1-2):15–25. doi: 10.1016/0378-1119(85)90065-4. [DOI] [PubMed] [Google Scholar]
  31. Wolfe J. H., Sands M. S., Barker J. E., Gwynn B., Rowe L. B., Vogler C. A., Birkenmeier E. H. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer. Nature. 1992 Dec 24;360(6406):749–753. doi: 10.1038/360749a0. [DOI] [PubMed] [Google Scholar]
  32. Wolfe J. H., Schuchman E. H., Stramm L. E., Concaugh E. A., Haskins M. E., Aguirre G. D., Patterson D. F., Desnick R. J., Gilboa E. Restoration of normal lysosomal function in mucopolysaccharidosis type VII cells by retroviral vector-mediated gene transfer. Proc Natl Acad Sci U S A. 1990 Apr;87(8):2877–2881. doi: 10.1073/pnas.87.8.2877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Yeager A. M., Brennan S., Tiffany C., Moser H. W., Santos G. W. Prolonged survival and remyelination after hematopoietic cell transplantation in the twitcher mouse. Science. 1984 Sep 7;225(4666):1052–1054. doi: 10.1126/science.6382609. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES